CD38 and melanoma: CD38 participates in adenosine generation via the CD203a/CD73 pathway, in selected tumors such as non-small-cell lung cancer (NSCLC) and melanoma, where the increased CD38 expression contributes to increased adenosine production and immunosuppressive effects [76,77].